Krajina: Kanada
Jazyk: angličtina
Zdroj: Health Canada
TIMOLOL (TIMOLOL MALEATE)
MYLAN PHARMACEUTICALS ULC
S01ED01
TIMOLOL
0.25%
SOLUTION
TIMOLOL (TIMOLOL MALEATE) 0.25%
OPHTHALMIC
5ML/10ML
Prescription
BETA-ADRENERGIC AGENTS
Active ingredient group (AIG) number: 0131275001; AHFS:
CANCELLED POST MARKET
2012-10-19
PRODUCT MONOGRAPH PR MYLAN-TIMOLOL (Timolol Maleate Ophthalmic Solution) Ophthalmic Solution 0.25% and 0.5% USP Elevated Intraocular Pressure Therapy Mylan Pharmaceuticals ULC DATE OF REVISION : 85 Advance Road JULY 20, 2010 Etobicoke, Ontario M8Z 2S6 CONTROL # 137993 2 TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ………………………………3 SUMMARY PRODUCT INFORMATION………………………………………………... 3 INDICATIONS AND CLINICAL USE……………………………………………………. 3 CONTRAINDICATIONS………………………………………………………………. 3 WARNINGS AND PRECAUTIONS……………………………………………………. 4 ADVERSE REACTIONS……………………………………………………………….. 6 DRUG INTERACTIONS……………………………………………………………….. 8 DOSAGE AND ADMINISTRATION……………………………………………………. 9 OVERDOSAGE………………………………………………………………………. 10 ACTION AND CLINICAL PHARMACOLOGY…………………………………………. 10 STORAGE AND STABILITY………………………………………………………….. 11 DOSAGE FORMS, COMPOSITION AND PACKAGING………………………………. 11 PART II: SCIENTIFIC INFORMATION …………………………………………… 13 PHARMACEUTICAL INFORMATION………………………………………………….. 13 CLINICAL TRIALS…………………………………………………………………….. 13 DETAILED PHARMACOLOGY………………………………………………………. 14 TOXICOLOGY……………………………………………………………………….. 14 BIBLIOGRAPHY……………………………………………………………………… 17 PART III: CONSUMER INFORMATION …………………………………………….. 19 3 PR MYLAN-TIMOLOL Timolol Maleate Ophthalmi Prečítajte si celý dokument